nocodazole and palbociclib

nocodazole has been researched along with palbociclib in 2 studies

Research

Studies (2)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's1 (50.00)24.3611
2020's1 (50.00)2.80

Authors

AuthorsStudies
Arbačiauskienė, E; Holzer, W; Jorda, R; Kryštof, V; Malínková, V; Milišiūnaitė, V; Řezníčková, E; Šačkus, A; Žukauskaitė, A1
Carnevalli, LS; Dunlop, CR; Fernández, SBQ; Jodrell, DI; Johnson, TI; Kottmann, D; Lau, A; Minteer, CJ; Richards, FM; Wallez, Y1

Other Studies

2 other study(ies) available for nocodazole and palbociclib

ArticleYear
Synthesis and anti-mitotic activity of 2,4- or 2,6-disubstituted- and 2,4,6-trisubstituted-2H-pyrazolo[4,3-c]pyridines.
    European journal of medicinal chemistry, 2018, Apr-25, Volume: 150

    Topics: Antimitotic Agents; Antineoplastic Agents; Cell Cycle Checkpoints; Cell Death; Cell Proliferation; Dose-Response Relationship, Drug; Drug Screening Assays, Antitumor; Humans; K562 Cells; MCF-7 Cells; Mitosis; Molecular Structure; Pyridines; Structure-Activity Relationship

2018
Quantifying cell cycle-dependent drug sensitivities in cancer using a high throughput synchronisation and screening approach.
    EBioMedicine, 2021, Volume: 68

    Topics: Cell Culture Techniques; Cell Cycle; Cell Line, Tumor; Cell Proliferation; Cell Survival; Deoxycytidine; Drug Screening Assays, Antitumor; Drug Synergism; Gemcitabine; HeLa Cells; High-Throughput Screening Assays; Humans; MCF-7 Cells; Neoplasms; Nocodazole; Piperazines; Pyridines; Small Molecule Libraries; Time Factors; Tubulin Modulators

2021